Bioimmunate’s technology is able to recognize MS related cells and to capture them. Removal of those cells will prevent their migration to the Central Nervous System. As these cells comprise only a very small fraction of blood cells, their targeted removal is a very safe procedure that does not cause neither immune suppression nor immune dysfunction.